Emory University’s Loxo Oncology, Inc LOXO Stock Holding History

Emory University’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-34,143	Closed	-$2.74M	–	58
2017 Q2	$2.74M	Buy	+34,143	New	+$1.89M	2.42%	2

Other funds holding LOXO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Emory University's LOXO Position: Q3 2017 in Review

Emory University sold out of Loxo Oncology, Inc (LOXO) in Q3 2017, closing a stake of 34,143 shares — an estimated $2.74M sold.

Emory University first reported a position in LOXO in Q2 2017 and held it in 1 quarter. The position peaked at $2.74M in Q2 2017. 148 funds tracked by Wall St. Rank hold LOXO as of Q3 2017.

Emory University reported no remaining Loxo Oncology, Inc position as of Q3 2017 after selling out during the quarter.
Emory University sold 34,143 Loxo Oncology, Inc shares in Q3 2017, an estimated $2.74M.
Emory University first reported a position in Loxo Oncology, Inc in Q2 2017 and held it in 1 quarter.
Emory University's Loxo Oncology, Inc position peaked at $2.74M in Q2 2017.
148 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q3 2017.

Based on Emory University's 13F filing for Q3 2017, filed 14 Nov 2017.